Targeting Angiogenesis in Squamous Cell Carcinoma of the Head and Neck: Opportunities in the Immunotherapy Era

Targeting Angiogenesis in Squamous Cell Carcinoma of the Head and Neck: Opportunities in the Immunotherapy Era

Despite the lack of approved anti-angiogenic therapies in squamous cell carcinoma of the head and neck (SCCHN), preclinical and more recent clinical evidence support the role of targeting the vascular endothelial growth factor (VEGF) in this disease. Targeting VEGF has gained even greater interest f...

Full description

Bibliographic Details
Main Authors: Nabil F. Saba, Pooja Vijayvargiya, Jan B. Vermorken, Juan P. Rodrigo, Stefan M. Willems, Nina Zidar, Remco de Bree, Antti Mäkitie, Greg T. Wolf, Athanassios Argiris, Yong Teng, Alfio Ferlito
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Cancers
Subjects:
angiogenesis
immunotherapy
VEGF
SCCHN
tumor microenvironment
Online Access:https://www.mdpi.com/2072-6694/14/5/1202

Internet

https://www.mdpi.com/2072-6694/14/5/1202

Similar Items